However, RAS‐activated cancers exhibit an increase in immune checkpoint molecules on their surface that bind to T‐cells and inhibit their function, while simultaneously exhibiting a decrease in MHC molecules on their surface which contributes to tumor cell immune evasion.33 This evidence concerns the gene HLA-C and neoplasm.